Phospho-eNOS (Ser1177)抗体特异性结合抗原:抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞,通常需要补体或吞噬细胞等共同发挥效应以**病原微生物或导致病理损伤。然而,抗体可通过与病毒或**的特异性结合,直接发挥中和病毒的作用。
	产品编号xy- 3447R
	
		英文名称Phospho-eNOS (Ser1177)
	
	
		中文名称磷酸化一氧化氮合成酶3(内皮型)抗体
	
	
		别    名eNOS (phospho S1177); eNOS(phospho S1177); p-eNOS (phospho S1177); eNOS (Phospho-Ser1177); cNOS; Constitutive NOS; EC NOS; ecNOS; Endothelial nitric oxidase synthase; Endothelial nitric oxide synthase; Endothelial nitric oxide synthase 3; Endothelial NOS; Nitric oxide synthase 3 (endothelial cell); Nitric oxide synthase 3; Nitric oxide synthase 3 endothelial cell; Nitric oxide synthase endothelial; nitric oxide synthase, endothelial; NOS 3; NOS III; NOS type III; NOS3; NOSIII; NOS3_HUMAN.  
	
	
		JournalPMIDIFApplicationBone (2013)233132823.8230WB
	
	
		说 明 书100ul  
	
	
		产品类型磷酸化抗体
	
	
		研究领域肿瘤  细胞生物  **学  神经生物学  信号转导  转录调节因子  激酶和磷酸酶  合成与降解  新陈代谢  
	
	
		抗体来源Rabbit
	
	
		克隆类型Polyclonal
	
	
		Phospho-eNOS (Ser1177)抗体交叉反应 Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Sheep, Guinea Pig,
	
	
		产品应用WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 Flow-Cyt=2μg /Test IF=1:100-500 (石蜡切片需做抗原修复)
	
	
		not yet tested in other applications.
	
	
		optimal dilutions/concentrations should be determined by the end user.
	
	
		分 子 量133kDa
	
	
		细胞定位细胞浆 细胞膜
	
	
		性    状Lyophilized or Liquid
	
	
		浓    度1mg/1ml
	
	
		免 疫 原KLH conjugated Synthesised phosphopeptide derived from human eNOS around the phosphorylation site of Ser1177:TQ(p-S)FS
	
	
		亚    型IgG
	
	
		纯化方法affinity purified by Protein A
	
	
		储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
	
	
		Phospho-eNOS (Ser1177)抗体保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
	
	
		PubMedPubMed
	
	
		产品介绍background:
	
	
		eNOS is a calcium/calmodulin dependent enzyme which undergoes several post translational modifications, including acylation with myristate and palmitate, and phosphorylation on numerous residues. As with the other members of the NOS family, eNOS derives the diffusible multifunctional second messenger NO from L arginine through a series of reactions in which L citrulline is an intermediate. eNOS plays an important role in controlling vascular tone, platelet aggregation, and cardiac myocyte function.
	
	
		
	
	
		Function:
	
	
		Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.
	
	
		Isoform eNOS13C: Lacks eNOS activity, dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1.
	
	
		
	
	
		Subunit:
	
	
		Homodimer. Interacts with NOSIP and NOSTRIN.
	
	
		
	
	
		Subcellular Location:
	
	
		Cell membrane. Membrane, caveola. Cytoplasm, cytoskeleton. Golgi apparatus. Note=Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced enzymatic activity.
	
	
		
	
	
		Tissue Specificity:
	
	
		Platelets, placenta, liver and kidney.
	
	
		
	
	
		Post-translational modifications:
	
	
		Phosphorylation by AMPK at Ser-1177 in the presence of Ca(2+)-calmodulin (CaM) activates activity. In absence of Ca(2+)-calmodulin, AMPK also phosphorylates Thr-495, resulting in inhibition of activity. Phosphorylation of Ser-114 by CDK5 reduces activity.
	
	
		
	
	
		Similarity:
	
	
		Belongs to the NOS family.
	
	
		Contains 1 FAD-binding FR-type domain.
	
	
		Contains 1 flavodoxin-like domain.
	
	
		
	
	
		SWISS:
	
	
		P29474
	
	
		
	
	
		Gene ID:
	
	
		4846
	
	Phospho-eNOS (Ser1177)抗体(antibody,
Ab)是由效应B细胞(效应**B细胞)分泌,机体用于抵御外来物质,如病毒,**等抗原,结构呈“Y”字型的球状蛋白质,仅仅存在于脊椎动物的血液和B**细胞膜表面。凡是能够跟抗体结合的物质,均被称作抗原,因此对于抗抗体(能够结合抗体的抗体)来说,抗体本身也是一种抗原物质。 
	    
	Phospho-eNOS (Ser1177)抗体普通抗体重链和轻链的结构 
	重链结构:普通的**球蛋白具有2条重链(H链),分子量约为50kD,有μ、δ、γ、ε和α五种重链亚型,对应的**球蛋白名称分别为IgM、IgG、IgA、IgD和IgE。 
	轻链结构:  普通**球蛋白具有2条轻链(L链),分子质量约25kDa,有κ链和λ链两种亚型,这两种轻链决定了Ig的亚型类别(IgG1,IgG2,IgG3,IgG4)。一个天然的Ig分子两条轻链总是相同的,但在同一个体内可存在分别带有κ或λ链的抗体分子。不同种属生物体内两型轻链的比例不同,正常人血清**球蛋白κ链:λ链约为2:1,而在小鼠的比例为20:1。 
	2.2抗体Fab段和Fc段 
	IgG经木瓜蛋白酶酶切后裂解为2个完全相同的Fab段和1个Fc段,每个Fab段都为单价,可与抗原结合但不会再发生凝集反应;经胃蛋白酶酶切后裂解为1个完整F(ab)2片段和碎片化的Fc片段,F(ab’)2片段为双价,可同时结合两个抗原表位。Fab段为抗原结合片段(fragment of antigen binding,Fab),相当于抗体分子的两个臂,由一个完整的轻链和重链的VH和CH1结构域组成。Fc段为可结晶段(fragment crystallizable,Fc)相当于Ig的CH2和CH3结构域,是Ig与效应分子或者细胞相互作用的部位。Fab段包含完整的可变区,以及恒定区的CH1区域。Fc段仅指Ig恒定区CH2和CH3的区域,相当于Y字结构下面那一部分。 
	合格		SLC39A11	溶质载体家族39成员11抗体
合格		XTP4	乙型肝炎病毒X蛋白反转录蛋白4抗体
合格		C17orf42	17号染色体开放阅读框42抗体
合格	合格		C17orf57	17号染色体开放阅读框57抗体
合格		C17orf74	17号染色体开放阅读框74抗体
合格		C17orf75	17号染色体开放阅读框75抗体
合格		C17orf77	17号染色体开放阅读框77抗体
合格		C17orf78	17号染色体开放阅读框78抗体
合格		C17orf82	17号染色体开放阅读框82抗体
合格	合格		C17orf97	17号染色体开放阅读框97抗体
合格		合格	pan 14-3-3	14-3-3蛋白抗体
合格		RIMKLA	核糖体蛋白S6修饰样蛋白A抗体
合格			FAM76B	FAM76B蛋白抗体
合格			ENAH	ENAH蛋白抗体
合格		EGFL8	表皮生长因子样蛋白8抗体
合格		C8orf70	8号染色体开放阅读框70抗体
合格	合格		LAS2	肺腺瘤易感蛋白2抗体
合格		C19orf21	19号染色体开放阅读框21抗体
合格			C19orf46	突触核膜蛋白4抗体
合格		C19orf47	19号染色体开放阅读框47抗体
合格		C19orf54	19号染色体开放阅读框54抗体
合格		VGLUT2	囊泡谷氨酸转运蛋白2抗体
合格	合格		Phospho-BLNK(Tyr189)	磷酸化T**细胞连接蛋白抗体
合格		C20orf11	20号染色体开放阅读框11抗体
合格		C20orf196	20号染色体开放阅读框196抗体
合格			C20orf43	20号染色体开放阅读框43抗体
合格		HECA	HECA蛋白抗体
合格		合格	ITM2A	完整膜蛋白E25A抗体
合格			NOP2	增殖相关核仁抗原抗体
合格		KBP	KBP蛋白抗体
合格		PDE4A8	磷酸二酯酶4A8抗体
合格	合格		C10orf27	第10号染色体开放阅读框27抗体
合格	合格		FAM29A	FAM29蛋白抗体
合格			BIN2	乳腺癌相关蛋白1抗体
合格			CNTD	细胞周期蛋白N端结构域蛋白1抗体
合格	CD34	CD34抗体
合格	phospho-Stathmin 1 (Ser63)	磷酸化原癌基因蛋白18抗体